CorTechs Labs, Inc., a San Diego, CA-based medical software developer, raised a Series B financing of undisclosed amount.
The round was led by Genting Berhad via its indirect wholly-owned subsidiary, Dragasac Limited, a company incorporated in the Isle of Man.
The company intends to use the funds to accelerate the development of its image analysis software and expand its sales and marketing initiatives.
Led by Guri Stark, CEO, CorTechs develops NeuroQuant®, a 510(k) cleared software solution for the quantification of volumetric brain atrophy to help diagnose a variety of brain disorders.
It has been used by neurologists, radiologists and clinical researchers to scan and analyze over 40,000 brain MRI scans around the world.